The Time-Restricted Intake of Meals Study (TRIM)
Primary Purpose
PreDiabetes, Obesity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Time-restricted feeding
Usual feeding pattern
Sponsored by
About this trial
This is an interventional prevention trial for PreDiabetes
Eligibility Criteria
Inclusion Criteria:
- Prediabetes defined by HbA1c 5.7-6.4%, or type 2 diabetes with HbA1c 6.5-6.9%
- Class I-III obesity (BMI 30-50 kg/m2)
- If on medications for hypertension, stable regimen for at least past 6 months
- Willingness to adjust timing of feeding
- Willingness and ability to eat study diet and nothing else during run-in and intervention
- Willingness to complete measurement procedures
Exclusion Criteria:
- Moderate to severe obstructive sleep apnea
- Shift work;
- Other sleep/circadian disorders: e.g., circadian phase delay or phase advance; restless legs syndrome, insomnia, narcolepsy, habitual sleep <6 hours/night
- Routinely ate within compressed time window in the past year (e.g., routinely eats all food within an 10-hour or narrower window, follows an intermittent fasting protocol)
- Renal dysfunction (estimated Glomerular Filtration Rate (GFR) <30 using the simplified Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) equation 34)
- Use of glucose-lowering medications, weight loss medications, medications for sleep disorders (sedative/hypnotic drugs, stimulants), lithium, systemic corticosteroids, diuretics, blood thinners requiring regular monitoring (e.g. warfarin), anti-psychotic drugs and antiretroviral therapy
- Body weight >400 pounds (limitation of facility scales)
- >1 drink per day of alcohol
- Active substance use disorder or significant psychiatric/psychologic disorder that would interfere with participation
- Significant food allergies, preferences, intolerances, or dietary supplements that would interfere with diet adherence
- Weight loss or gain of ≥5% during past 6 months
- Pregnant, planning to become pregnant, or breastfeeding
- Planning to start a weight loss program
- Planning to leave the area prior to end of study
- Current participation in another clinical trial
- Cancer diagnosis requiring active treatment in past two years or planned treatment (with exception of localized non-melanoma skin cancer)
- Active inflammatory bowel disease, malabsorption, or history of major gastrointestinal surgery involving bowel resection
- Myocardial infarction or stroke in past 6 months
- Prior bariatric surgery
- Any serious illness that would interfere with participation
- Other conditions or situations at the discretion of the PI
Sites / Locations
- Johns Hopkins ProHealth
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Time-restricted feeding
Usual feeding pattern
Arm Description
Comparison
Outcomes
Primary Outcome Measures
Weight Change
Weight change will be measured in kg
Secondary Outcome Measures
Fasting glucose
Change in fasting glucose
HOMA-IR
Change in HOMA-IR
AUC glucose
Area-under-the-curve for glucose on OGTT
Glycated albumin
Glycated albumin
Full Information
NCT ID
NCT03527368
First Posted
May 4, 2018
Last Updated
May 13, 2021
Sponsor
Johns Hopkins University
Collaborators
American Heart Association
1. Study Identification
Unique Protocol Identification Number
NCT03527368
Brief Title
The Time-Restricted Intake of Meals Study
Acronym
TRIM
Official Title
The Time-Restricted Intake of Meals Study: A Randomized, Controlled Feeding Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
September 24, 2018 (Actual)
Primary Completion Date
December 23, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
American Heart Association
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
TRIM is a randomized, controlled feeding study to evaluate if eating earlier in the day vs. later in the day impacts weight and glucose homeostasis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PreDiabetes, Obesity
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
41 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Time-restricted feeding
Arm Type
Experimental
Arm Title
Usual feeding pattern
Arm Type
Other
Arm Description
Comparison
Intervention Type
Behavioral
Intervention Name(s)
Time-restricted feeding
Intervention Description
Participants consume food earlier in the day
Intervention Type
Behavioral
Intervention Name(s)
Usual feeding pattern
Intervention Description
Participants consume food later in the day
Primary Outcome Measure Information:
Title
Weight Change
Description
Weight change will be measured in kg
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Fasting glucose
Description
Change in fasting glucose
Time Frame
12 weeks
Title
HOMA-IR
Description
Change in HOMA-IR
Time Frame
12 weeks
Title
AUC glucose
Description
Area-under-the-curve for glucose on OGTT
Time Frame
12 weeks
Title
Glycated albumin
Description
Glycated albumin
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Prediabetes defined by HbA1c 5.7-6.4%, or type 2 diabetes with HbA1c 6.5-6.9%
Class I-III obesity (BMI 30-50 kg/m2)
If on medications for hypertension, stable regimen for at least past 6 months
Willingness to adjust timing of feeding
Willingness and ability to eat study diet and nothing else during run-in and intervention
Willingness to complete measurement procedures
Exclusion Criteria:
Moderate to severe obstructive sleep apnea
Shift work;
Other sleep/circadian disorders: e.g., circadian phase delay or phase advance; restless legs syndrome, insomnia, narcolepsy, habitual sleep <6 hours/night
Routinely ate within compressed time window in the past year (e.g., routinely eats all food within an 10-hour or narrower window, follows an intermittent fasting protocol)
Renal dysfunction (estimated Glomerular Filtration Rate (GFR) <30 using the simplified Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) equation 34)
Use of glucose-lowering medications, weight loss medications, medications for sleep disorders (sedative/hypnotic drugs, stimulants), lithium, systemic corticosteroids, diuretics, blood thinners requiring regular monitoring (e.g. warfarin), anti-psychotic drugs and antiretroviral therapy
Body weight >400 pounds (limitation of facility scales)
>1 drink per day of alcohol
Active substance use disorder or significant psychiatric/psychologic disorder that would interfere with participation
Significant food allergies, preferences, intolerances, or dietary supplements that would interfere with diet adherence
Weight loss or gain of ≥5% during past 6 months
Pregnant, planning to become pregnant, or breastfeeding
Planning to start a weight loss program
Planning to leave the area prior to end of study
Current participation in another clinical trial
Cancer diagnosis requiring active treatment in past two years or planned treatment (with exception of localized non-melanoma skin cancer)
Active inflammatory bowel disease, malabsorption, or history of major gastrointestinal surgery involving bowel resection
Myocardial infarction or stroke in past 6 months
Prior bariatric surgery
Any serious illness that would interfere with participation
Other conditions or situations at the discretion of the PI
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nisa Maruthur, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins ProHealth
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21207
Country
United States
12. IPD Sharing Statement
Learn more about this trial
The Time-Restricted Intake of Meals Study
We'll reach out to this number within 24 hrs